The prize went to Jennifer Doudna of the University of California Berkeley and Emmanuelle Charpentier of the Max Planck Institute. Charpentier published her research on the biology behind the technology in 2011 and collaborated with Doudna. The two discovered it was possible to control the mechanism.
The Nobel Prize in Medicine or Physiology went to Drs. William Kaelin, Gregg Semenza and Peter Ratcliffe. Their research has led to new strategies for treating diseases like cancers and anemia.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Also news on Cell Therapy, Spark Therapeutics and the quest for an electronic data standard.
Many women and science can't deny that they are #distractinglysexy in the lab. Looks like Sir Tim Hunt was right.
Well, this is tragic. James Watson – yes, the Watson & Crick Watson – is auctioning off his Nobel Prize because he’s short of cash. Ever since a public outing of some IQ-related racist comments, the laureate told the Financial Times that he’s now considered an “unperson.” Watson, who earned the accolade in 1962 for discovering the structure of DNA, will auction off […]
We’re coming up on Nobel Prize announcement season next week and that means the betting, or at least speculation, is on for who will be the award recipients. Thomson Reuters has some ideas on the subject spanning each category. It sees DNA methylation and gene expression in the growing field of epigenetics as well as the […]
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.